Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/156561
Title: | Serum alkaline phosphatase relates to cardiovascular risk markers in children with high calcium-phosphorus product |
Author: | Xargay i Torrent, Sílvia Espuña Capote, Núria Montesinos Costa, Mercè Prats Puig, Anna Carreras Badosa, Gemma Díaz Roldán, Ferran Zegher, Francis de Ibáñez Toda, Lourdes Bassols, Judit López Bermejo, Abel |
Keywords: | Malalties cardiovasculars Factors de risc en les malalties Malalties dels infants Cardiovascular diseases Risk factors in diseases Children's diseases |
Issue Date: | 14-Dec-2018 |
Publisher: | Nature Publishing Group |
Abstract: | Although alkaline phosphatase (ALP) correlates with cardiovascular risk in adults, there are no studies in children. We evaluated the association between serum ALP levels, calcium-phosphorus product (Ca*P) and cardiovascular risk markers in healthy children. Children aged 7.9 ± 1.4 (n = 379) were recruited in this cross-sectional study. The main outcome measures were systolic and diastolic blood pressure (SBP and DBP) and carotid intima-media thickness (cIMT). Additional assessments were body-mass index (BMI), waist circumference, homeostatic model assessment of insulin resistance (HOMA-IR) and fasting lipids, ALP, serum calcium, phosphorus and Ca*P. ALP was directly correlated with BMI (p < 0.0001), waist circumference (p < 0.0001), SBP (p < 0.0001), cIMT (p = 0.005), HOMA-IR (p < 0.0001), and fasting triglycerides (p = 0.0001). Among them, in children with Ca*P values above the median the associations were BMI (r = 0.231; p = 0.001), waist (r = 0.252; p < 0.0001), SBP (r = 0.324; p < 0.0001), cIMT (r = 0.248; p = 0.001) and HOMA-IR (r = 0.291; p < 0.0001)]. ALP independently associated with SBP (β = 0.290, p < 0.001) and cIMT (β = 0.179, p = 0.013) in children with higher Ca*P, after adjusting for confounding variables. Circulating ALP is associated with a more adverse cardiovascular profile in children with higher Ca*P. We suggest that serum ALP and Ca*P levels could contribute to the assessment of risk for cardiovascular disease in children. |
Note: | Reproducció del document publicat a: https://doi.org/10.1038/s41598-018-35973-5 |
It is part of: | Scientific Reports, 2018, vol. 8, num. 1, p. 17864 |
URI: | http://hdl.handle.net/2445/156561 |
Related resource: | https://doi.org/10.1038/s41598-018-35973-5 |
ISSN: | 2045-2322 |
Appears in Collections: | Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
686335.pdf | 1.29 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License